Skip to main content

UPDATE 1-Moderna extends lipids deal to boost COVID-19 vaccine output

Moderna Inc has extended a deal to secure large volumes of the lipids used to produce its experimental COVID-19 vaccine in a bid to meet increasing demand for the medicine, the U.S. biotech company said on Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.